Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$72.54 - $95.56 $6.29 Million - $8.28 Million
86,648 New
86,648 $8.28 Million
Q3 2022

Nov 14, 2022

SELL
$82.37 - $107.29 $637,379 - $830,210
-7,738 Reduced 45.95%
9,103 $752,000
Q2 2022

Aug 15, 2022

BUY
$86.5 - $128.27 $1.46 Million - $2.16 Million
16,841 New
16,841 $1.6 Million
Q4 2021

Feb 14, 2022

SELL
$106.37 - $130.68 $230,078 - $282,660
-2,163 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$102.91 - $122.75 $1.69 Million - $2.02 Million
-16,445 Reduced 88.38%
2,163 $245,000
Q2 2021

Aug 16, 2021

BUY
$83.84 - $104.76 $930,288 - $1.16 Million
11,096 Added 147.71%
18,608 $1.93 Million
Q1 2021

May 17, 2021

BUY
$78.68 - $90.67 $591,044 - $681,113
7,512 New
7,512 $628,000
Q3 2020

Nov 16, 2020

SELL
$67.19 - $87.44 $645,695 - $840,298
-9,610 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$57.54 - $76.95 $552,959 - $739,489
9,610 New
9,610 $664,000
Q1 2020

May 15, 2020

SELL
$52.41 - $81.0 $691,445 - $1.07 Million
-13,193 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$71.7 - $82.09 $945,938 - $1.08 Million
13,193 New
13,193 $1.03 Million
Q3 2019

Nov 14, 2019

SELL
$61.55 - $75.43 $532,469 - $652,544
-8,651 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$55.74 - $64.41 $482,206 - $557,210
8,651 New
8,651 $1.6 Million
Q1 2019

May 15, 2019

SELL
$47.89 - $64.05 $329,770 - $441,048
-6,886 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$46.41 - $56.94 $319,579 - $392,088
6,886 New
6,886 $1.06 Million
Q3 2018

Nov 14, 2018

SELL
$45.7 - $58.03 $206,015 - $261,599
-4,508 Closed
0 $0
Q2 2018

Aug 03, 2018

BUY
$42.45 - $51.3 $109,351 - $132,148
2,576 Added 133.33%
4,508 $656,000
Q4 2017

Jan 30, 2018

SELL
$33.79 - $39.39 $150,737 - $175,718
-4,461 Reduced 69.78%
1,932 $218,000
Q3 2017

Nov 09, 2017

BUY
$36.29 - $38.83 $232,001 - $248,240
6,393
6,393 $698,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $40.5B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Lmr Partners LLP Portfolio

Follow Lmr Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Lmr Partners LLP with notifications on news.